Pharmala Biotech Holdings Inc.
MDMA
CNSX
| 02/28/2026 | 11/30/2025 | 08/31/2025 | 05/31/2025 | 02/28/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 423.50K | 645.20K | 699.30K | 905.30K | 1.05M |
| Total Receivables | 306.10K | 269.00K | 45.50K | 95.30K | 112.10K |
| Inventory | 283.80K | 256.00K | 269.10K | 278.00K | 238.40K |
| Prepaid Expenses | 2.40K | 7.30K | 184.90K | 56.20K | 50.90K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 1.02M | 1.18M | 1.20M | 1.33M | 1.45M |
|
|
|||||
| Total Current Assets | 1.02M | 1.18M | 1.20M | 1.33M | 1.45M |
| Net Property, Plant & Equipment | 1.80K | 1.90K | 2.10K | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 1.28M | 1.25M | 1.29M | 1.31M | 1.26M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | 0.00 | -- | -- | -- |
| Total Assets | 2.30M | 2.43M | 2.49M | 2.64M | 2.71M |
|
|
|||||
| Total Accounts Payable | 331.10K | 334.60K | 406.80K | 320.30K | 252.80K |
| Total Accrued Expenses | -- | -- | -- | -- | 6.30K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 382.70K | 400.90K | 293.20K | 316.60K | 303.80K |
| Total Other Current Liabilities | 382.70K | 400.90K | 293.20K | 316.60K | 303.80K |
| Total Current Liabilities | 713.80K | 735.40K | 700.10K | 636.90K | 562.80K |
|
|
|||||
| Total Current Liabilities | 713.80K | 735.40K | 700.10K | 636.90K | 562.80K |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | 0.00 | 0.00 |
| Total Liabilities | 713.80K | 735.40K | 700.10K | 636.90K | 562.80K |
|
|
|||||
| Common Stock & APIC | 6.46M | 6.22M | 6.09M | 6.03M | 5.62M |
| Retained Earnings | -5.78M | -5.40M | -5.19M | -4.92M | -4.33M |
| Treasury Stock & Other | 900.40K | 878.90K | 893.80K | 892.60K | 850.90K |
| Total Common Equity | 1.58M | 1.70M | 1.79M | 2.00M | 2.14M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 1.58M | 1.70M | 1.79M | 2.00M | 2.14M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1.58M | 1.70M | 1.79M | 2.00M | 2.14M |
|
|
|||||